Athira Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athira Pharma and other ETFs, options, and stocks.

About ATHA

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. 

CEO
Mark J. Litton
CEOMark J. Litton
Employees
26
Employees26
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
2011
Founded2011
Employees
26
Employees26

ATHA Key Statistics

Market cap
11.80M
Market cap11.80M
Price-Earnings ratio
-0.14
Price-Earnings ratio-0.14
Dividend yield
—
Dividend yield—
Average volume
171.39K
Average volume171.39K
High today
$0.3115
High today$0.3115
Low today
$0.296
Low today$0.296
Open price
$0.296
Open price$0.296
Volume
78.24K
Volume78.24K
52 Week high
$3.67
52 Week high$3.67
52 Week low
$0.2195
52 Week low$0.2195

People also own

Based on the portfolios of people who own ATHA. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
SNDL
Plug Power
Lucid Group
AMC Entertainment
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.